Antiviral treatment.

Antiviral treatment, SVR prevent esophageal varices in patients with HCV-induced cirrhosis Italian researchers have discovered that antiviral treatment and sustained virologic response prevents esophageal varices in individuals with compensated hepatitis C -induced cirrhosis, indicating that endoscopic surveillance could be delayed or avoided in these patients securely. In the June issue of Hepatology Full findings are published, a journal of the American Association for the analysis of Liver Diseases cialis beschreibung tadalafilschweiz.com . Based on the National Digestive Diseases Information Clearinghouse , an estimated 4.1 million Americans have antibody to HCV , indicating ongoing or previous disease with the virus.